News about Drug Discovery & Development

Alembic Secures US FDA Approval for Migraine Treatment Autoinjector

The approved product is therapeutically equivalent to the reference-listed drug, Imitrex STATdose System, priorly marketed by GlaxoSmithKline.

Drug Discovery & Development | 11/11/2025 | By Darshana |  100

ClearPoint Neuro Acquires IRRAS to Boost Neuro Drug Delivery Portfolio

Its cornerstone product is the IRRAflow system, a US FDA-cleared and CE-marked platform which integrates continuous irrigation, aspiration, and real-time intracranial pressure monitoring.

Drug Discovery & Development | 10/11/2025 | By Darshana |  172

US FDA Grants Six More Priority Review Vouchers to Accelerate Drug Approvals

The US Food and Drug Administration (FDA) has awarded six additional companies under its “Commissioner’s National Priority Voucher” programme, bringing the total number of recipients to fifteen.

Drug Discovery & Development | 07/11/2025 | By Darshana |  114

Nona Biosciences and Umoja Biopharma Expand Partnership to Advance In-vivo CAR-T Therapies

Under the terms of the agreement, Nona Biosciences is eligible to receive an upfront payment, potential option exercise fees and milestone payments tied to the discovery and development of specific programmes in the collaboration. Umoja will be responsible for all further product development and commercialisation.

Drug Discovery & Development | 07/11/2025 | By Dineshwori |  140

IIT Madras and Ohio State Researchers Develop AI Framework That Mimics Chemical Synthesis for Drug Discovery

Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.

Drug Discovery & Development | 06/11/2025 | By Darshana |  157

AmacaThera and Pacira BioSciences Partner to Develop Long-Acting Non-Opioid Anaesthetic for Post-Operative Pain

AmacaThera, a leading biotechnology company specialising in next-generation hydrogel-based drug delivery systems, has entered into an exclusive global licensing agreement with Pacira BioSciences, Inc., a leader in non-opioid pain management, to develop and commercialise AMT-143.

Drug Discovery & Development | 05/11/2025 | By Darshana

Alkem and IIT Bombay Collaborate to Launch R and D Centre for Advanced Immunotherapies

Alkem Laboratories, through its CSR arm, has partnered with IIT Bombay to establish the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics & Regenerative Medicines on the institute’s campus.

Drug Discovery & Development | 03/11/2025 | By Darshana |  113

FDA Grants Interchangeable Status to Celltrion's Denosumab Biosimilars Stoboclo and Osenvelt

The interchangeability (IC) designation allows Stoboclo and Osenvelt to be substituted at the pharmacy level for their reference biologics without requiring prescriber consultation, in accordance with state pharmacy laws.

Drug Discovery & Development | 31/10/2025 | By Darshana |  156

Boehringer Ingelheim Acquires Licence from Kyowa Kirin to Develop Treatment for Autoimmune Diseases

Boehringer Ingelheim has acquired a licence from Kyowa Kirin to develop a small molecule programme targeting autoimmune diseases. The collaboration aims to address significant unmet medical needs and strengthen Boehringer’s pipeline of innovative therapies for patients with inflammatory and immune-related conditions.

Drug Discovery & Development | 31/10/2025 | By Dineshwori |  127

ModeX and Regeneron Partner to Develop Multispecific Antibodies

ModeX Therapeutics has entered into a research collaboration with Regeneron to develop multispecific antibodies capable of targeting multiple biological pathways within a single molecule. The partnership, valued at over USD 1 Billion, if multiple assets advance, aims to accelerate innovation across select therapeutic areas.

Drug Discovery & Development | 30/10/2025 | By Dineshwori |  186